BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36227159)

  • 1. Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening.
    Shishodia S; Nuñez R; Strohmier BP; Bursch KL; Goetz CJ; Olp MD; Jensen DR; Fenske TG; Ordonez-Rubiano SC; Blau ME; Roach MK; Peterson FC; Volkman BF; Dykhuizen EC; Smith BC
    J Med Chem; 2022 Oct; 65(20):13714-13735. PubMed ID: 36227159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GNE-235: A Lead Compound Selective for the Second Bromodomain of PBRM1.
    Cochran AG; Flynn M
    J Med Chem; 2023 Sep; 66(18):13116-13134. PubMed ID: 37702400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression.
    Bursch KL; Goetz CJ; Jiao G; Nuñez R; Olp MD; Dhiman A; Khurana M; Zimmermann MT; Urrutia RA; Dykhuizen EC; Smith BC
    J Biol Chem; 2024 Apr; 300(4):107146. PubMed ID: 38460939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBRM1 bromodomains variably influence nucleosome interactions and cellular function.
    Slaughter MJ; Shanle EK; McFadden AW; Hollis ES; Suttle LE; Strahl BD; Davis IJ
    J Biol Chem; 2018 Aug; 293(35):13592-13603. PubMed ID: 29986887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBRM1 bromodomains associate with RNA to facilitate chromatin association.
    De Silva SM; Dhiman A; Sood S; Mercedes KF; Simmons WJ; Henen MA; Vögeli B; Dykhuizen EC; Musselman CA
    Nucleic Acids Res; 2023 May; 51(8):3631-3649. PubMed ID: 36808431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1.
    Taylor AM; Bailey C; Belmont LD; Campbell R; Cantone N; Côté A; Crawford TD; Cummings R; DeMent K; Duplessis M; Flynn M; Good AC; Huang HR; Joshi S; Leblanc Y; Murray J; Nasveschuk CG; Neiss A; Poy F; Romero FA; Sandy P; Tang Y; Tsui V; Zawadzke L; Sims RJ; Audia JE; Bellon SF; Magnuson SR; Albrecht BK; Cochran AG
    J Med Chem; 2022 Aug; 65(16):11177-11186. PubMed ID: 35930799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual Bromodomains of Polybromo-1 Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma.
    Porter EG; Dykhuizen EC
    J Biol Chem; 2017 Feb; 292(7):2601-2610. PubMed ID: 28053089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1.
    Liao L; Alicea-Velázquez NL; Langbein L; Niu X; Cai W; Cho EA; Zhang M; Greer CB; Yan Q; Cosgrove MS; Yang H
    Mol Oncol; 2019 Apr; 13(4):811-828. PubMed ID: 30585695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.
    Sutherell CL; Tallant C; Monteiro OP; Yapp C; Fuchs JE; Fedorov O; Siejka P; Müller S; Knapp S; Brenton JD; Brennan PE; Ley SV
    J Med Chem; 2016 May; 59(10):5095-101. PubMed ID: 27119626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.
    Yao X; Hong JH; Nargund AM; Ng MSW; Heng HL; Li Z; Guan P; Sugiura M; Chu PL; Wang LC; Ye X; Qu J; Kwek XY; Lim JCT; Ooi WF; Koh J; Wang Z; Pan YF; Ong YS; Tan KY; Goh JY; Ng SR; Pignata L; Huang D; Lezhava A; Tay ST; Lee M; Yeo XH; Tam WL; Rha SY; Li S; Guccione E; Futreal A; Tan J; Yeong JPS; Hong W; Yauch R; Chang KT; Sobota RM; Tan P; Teh BT
    Nat Cell Biol; 2023 May; 25(5):765-777. PubMed ID: 37095322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bromo-adjacent homology domains of PBRM1 associate with histone tails and contribute to PBAF-mediated gene regulation.
    Petell CJ; Burkholder NT; Ruiz PA; Skela J; Foreman JR; Southwell LE; Temple BR; Krajewski K; Strahl BD
    J Biol Chem; 2023 Aug; 299(8):104996. PubMed ID: 37394010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pbrm1 Steers Mesenchymal Stromal Cell Osteolineage Differentiation by Integrating PBAF-Dependent Chromatin Remodeling and BMP/TGF-β Signaling.
    Sinha S; Biswas M; Chatterjee SS; Kumar S; Sengupta A
    Cell Rep; 2020 Apr; 31(4):107570. PubMed ID: 32348751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
    Singh M; Popowicz GM; Krajewski M; Holak TA
    Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
    Faivre EJ; McDaniel KF; Albert DH; Mantena SR; Plotnik JP; Wilcox D; Zhang L; Bui MH; Sheppard GS; Wang L; Sehgal V; Lin X; Huang X; Lu X; Uziel T; Hessler P; Lam LT; Bellin RJ; Mehta G; Fidanze S; Pratt JK; Liu D; Hasvold LA; Sun C; Panchal SC; Nicolette JJ; Fossey SL; Park CH; Longenecker K; Bigelow L; Torrent M; Rosenberg SH; Kati WM; Shen Y
    Nature; 2020 Feb; 578(7794):306-310. PubMed ID: 31969702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.
    Hassan AH; Awad S; Al-Natour Z; Othman S; Mustafa F; Rizvi TA
    Biochem J; 2007 Feb; 402(1):125-33. PubMed ID: 17049045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.
    Mota M; Sweha SR; Pun M; Natarajan SK; Ding Y; Chung C; Hawes D; Yang F; Judkins AR; Samajdar S; Cao X; Xiao L; Parolia A; Chinnaiyan AM; Venneti S
    Proc Natl Acad Sci U S A; 2023 May; 120(18):e2221175120. PubMed ID: 37094128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological function and histone recognition of family IV bromodomain-containing proteins.
    Lloyd JT; Glass KC
    J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
    Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
    Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.
    Dudek AH; Pfaff F; Bolte H; Waguia Kontchou C; Schwemmle M
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29848589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.
    Shen W; Xu C; Huang W; Zhang J; Carlson JE; Tu X; Wu J; Shi Y
    Biochemistry; 2007 Feb; 46(8):2100-10. PubMed ID: 17274598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.